Ten out of 11 children with a form of congenital deafness who were treated with an experimental gene therapy developed by ...

The fully implanted Acclaim® cochlear implant received Breakthrough Device Designation from the FDA in 2019 and was first implanted in three participants during an early feasibility study (EFS) at ...